BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3973829)

  • 1. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    Lunam CA; Cousins MJ; Hall PD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):802-9. PubMed ID: 3973829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent binding of oxidative biotransformation intermediates is associated with halothane hepatotoxicity in guinea pigs.
    Lind RC; Gandolfi AJ; Hall PD
    Anesthesiology; 1990 Dec; 73(6):1208-13. PubMed ID: 2248397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney.
    Lind RC; Gandolfi AJ
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):201-7. PubMed ID: 9007050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathology of halothane hepatotoxicity in a guinea-pig model: a comparison with human halothane hepatitis.
    Lunam CA; Hall PM; Cousins MJ
    Br J Exp Pathol; 1989 Oct; 70(5):533-41. PubMed ID: 2818932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains.
    Gourlay GK; Adams JF; Cousins MJ; Hall P
    Anesthesiology; 1981 Aug; 55(2):96-103. PubMed ID: 7258721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model.
    Gourlay GK; Adams JF; Cousins MJ; Sharp JH
    Br J Anaesth; 1980 Mar; 52(3):331-6. PubMed ID: 7370149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of halothane, isoflurane, and blood loss on hepatotoxicity and hepatic oxygen availability in phenobarbital-pretreated hypoxic rats.
    Gelman S; Rimerman V; Fowler KC; Bishop SP; Bradley EL
    Anesth Analg; 1984 Nov; 63(11):965-72. PubMed ID: 6496981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halothane hepatotoxicity in guinea pigs.
    Lind RC; Gandolfi AJ; Brown BR; Hall PM
    Anesth Analg; 1987 Mar; 66(3):222-8. PubMed ID: 3826664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane.
    Sipes IG; Gandolfi AJ; Pohl LR; Krishna G; Brown BR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):716-20. PubMed ID: 7400974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Injury following halothane, enflurane, and isoflurane anesthesia in rats.
    Harper MH; Collins P; Johnson B; Eger EI; Biava C
    Anesthesiology; 1982 Jan; 56(1):14-7. PubMed ID: 7053663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative toxicity of halothane, isoflurane, hypoxia, and phenobarbital induction in monolayer cultures of rat hepatocytes.
    Schieble TM; Costa AK; Heffel DF; Trudell JR
    Anesthesiology; 1988 Apr; 68(4):485-94. PubMed ID: 3354886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predisposition to liver damage after halothane anesthesia in guinea pigs.
    Lunam CA; Cousins MJ; Hall PM
    Anesth Analg; 1986 Nov; 65(11):1143-8. PubMed ID: 3767012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of covalently bound halothane metabolites in the hypoxic rat model for halothane hepatotoxicity.
    Gandolfi AJ; Sipes IG; Brown BR
    Fundam Appl Toxicol; 1981; 1(3):255-9. PubMed ID: 7184790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxidative biotransformation of halothane in the guinea pig model of halothane-associated hepatotoxicity.
    Lind RC; Gandolfi AJ; Hall PD
    Anesthesiology; 1989 Apr; 70(4):649-53. PubMed ID: 2930002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halothane hepatitis in an animal model: time course of hepatic damage.
    Knights KM; Gourlay GK; Hall PD; Adams JF; Cousins MJ
    Br J Exp Pathol; 1987 Oct; 68(5):613-24. PubMed ID: 3689669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid potentiation of a guinea pig model of halothane-associated hepatotoxicity.
    Lind RC; Gandolfi AJ; Hall PM
    J Appl Toxicol; 1990 Jun; 10(3):161-5. PubMed ID: 2380477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity.
    Cousins MJ; Sharp JH; Gourlay GK; Adams JF; Haynes WD; Whitehead R
    Anaesth Intensive Care; 1979 Feb; 7(1):9-24. PubMed ID: 434454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.
    McLain GE; Sipes IG; Brown BR
    Anesthesiology; 1979 Oct; 51(4):321-6. PubMed ID: 484893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration-dependent inhibition of halothane biotransformation in the guinea pig.
    Lind RC; Gandolfi AJ
    Drug Metab Dispos; 1993; 21(2):386-9. PubMed ID: 8097713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.